A Study to Assess the Concentration of Rozanolixizumab in the Breast Milk of Healthy Lactating Women

Clinical trial NCT06720714 · COMPLETED

Trial details

NCT number: NCT06720714
Sponsor: UCB Biopharma SRL
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Healthy Participants

Start date: 2024-12-03
Primary completion: 2025-05-12
Enrollment: 15

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.